Position in BIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,253,555
+$420,742 QoQ
Shares Held
45,140
-1.9% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 397 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,264,483,794 across 83 Medical Devices names. BIO ranks #16 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in BIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,253,555 | 45,140 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $12,832,813 | 46,037 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,754,534 | 45,396 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,595,550 | 48,488 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,100,991 | 50,145 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $18,146,280 | 54,236 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,521,433 | 34,863 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $12,907,868 | 37,320 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,108,375 | 37,500 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $13,151,530 | 36,690 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $13,875,792 | 36,600 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $17,939,299 | 37,450 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $15,353,771 | 36,514 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,564,443 | 34,915 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $17,004,240 | 34,352 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $16,678,366 | 29,612 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $40,191,790 | 53,194 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $36,102,488 | 48,398 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $31,196,521 | 48,420 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $26,236,122 | 45,934 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $27,459,388 | 47,105 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $26,103,409 | 50,641 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $24,870,326 | 55,085 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $19,960,535 | 56,939 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||